Richard A Crosby1,2, Tom Collins1. 1. College of Public Health, University of Kentucky, Lexington, Kentucky. 2. University of Mississippi Medical Center, Jackson, Mississippi.
Abstract
OBJECTIVE: One largely unexplored barrier to colorectal cancer (CRC) screening is fatalistic beliefs about cancer. The purpose of this study was to identify correlates of ever having endoscopy screenings for CRC and to determine whether fatalism plays a unique role. Because evidence suggests that cancer-associated fatalistic beliefs may be particularly common among rural Americans, the study was conducted in a medically underserved area of rural Appalachia. METHODS: Rural residents (N = 260) between 51 and 75 years of age, from a medically underserved area of Appalachia, Kentucky, were recruited for a cross-sectional study. The outcome measure was assessed by a single item asking whether participants ever had a colonoscopy or flexible sigmoidoscopy. Demographic and health-related correlates of this outcome were selected based on past studies of rural populations. A single item assessed perceptions of fatalism regarding CRC. Age-adjusted analyses of correlates testing significant at the bivariate level were conducted. RESULTS: The analytic sample was limited to 135 rural residents indicating they had ever had CRC endoscopy and 107 indicating never having endoscopy. In age-adjusted analyses, only the measure of fatalism had a significant association with having endoscopy. Those endorsing the statement pertaining to fatalism were 2.3 times more likely (95% CI = 1.24-4.27, P = .008) than the remainder to indicate never having endoscopy. CONCLUSIONS: A community-based approach to the promotion of endoscopy for CRC screening could focus on overcoming CRC-associated fatalism, thereby potentially bringing more unscreened people to endoscopy clinics.
OBJECTIVE: One largely unexplored barrier to colorectal cancer (CRC) screening is fatalistic beliefs about cancer. The purpose of this study was to identify correlates of ever having endoscopy screenings for CRC and to determine whether fatalism plays a unique role. Because evidence suggests that cancer-associated fatalistic beliefs may be particularly common among rural Americans, the study was conducted in a medically underserved area of rural Appalachia. METHODS: Rural residents (N = 260) between 51 and 75 years of age, from a medically underserved area of Appalachia, Kentucky, were recruited for a cross-sectional study. The outcome measure was assessed by a single item asking whether participants ever had a colonoscopy or flexible sigmoidoscopy. Demographic and health-related correlates of this outcome were selected based on past studies of rural populations. A single item assessed perceptions of fatalism regarding CRC. Age-adjusted analyses of correlates testing significant at the bivariate level were conducted. RESULTS: The analytic sample was limited to 135 rural residents indicating they had ever had CRC endoscopy and 107 indicating never having endoscopy. In age-adjusted analyses, only the measure of fatalism had a significant association with having endoscopy. Those endorsing the statement pertaining to fatalism were 2.3 times more likely (95% CI = 1.24-4.27, P = .008) than the remainder to indicate never having endoscopy. CONCLUSIONS: A community-based approach to the promotion of endoscopy for CRC screening could focus on overcoming CRC-associated fatalism, thereby potentially bringing more unscreened people to endoscopy clinics.
Authors: Tyler Hinshaw; Suzanne Lea; Justin Arcury; Alexander A Parikh; Rebecca A Snyder Journal: Cancer Causes Control Date: 2021-01-04 Impact factor: 2.506
Authors: Jakob D Jensen; Jackilen Shannon; Ronaldo Iachan; Yangyang Deng; Sunny Jung Kim; Wendy Demark-Wahnefried; Babalola Faseru; Electra D Paskett; Jinxiang Hu; Robin C Vanderpool; DeAnn Lazovich; Jason A Mendoza; Sanjay Shete; Linda B Robertson; Rajesh Balkrishnan; Katherine J Briant; Benjamin Haaland; David A Haggstrom; Bernard F Fuemmeler Journal: Cancer Epidemiol Biomarkers Prev Date: 2022-01-28 Impact factor: 4.090
Authors: Jennifer L Moss; Casey N Pinto; Shobha Srinivasan; Kathleen A Cronin; Robert T Croyle Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-10 Impact factor: 4.254
Authors: Yi Guo; Sarah M Szurek; Jiang Bian; Dejana Braithwaite; Jonathan D Licht; Elizabeth A Shenkman Journal: Cancer Med Date: 2021-07-13 Impact factor: 4.711